Atrial fibrillation (AF) is an uncommon arrhythmia in young adults without structural heart disease, and cryoballoon pulmonary vein isolation (CB-PVI) is an important therapeutic strategy for rhythm control in patients with drug-refractory AF. The aim of this analysis was to evaluate efficacy and safety of CB-PVI in a large cohort of young patients in comparison with middle-aged adults in a real-world setting.
Reference: Safety and efficacy of cryoablation for atrial fibrillation in young patients: A multicenter experience in the 1STOP project. Bertaglia E, Iacopino S, Verlato R, Arena G, Pieragnoli P, Tondo C, Molon G, Manfrin M, Perego GB, Rovaris G, Rivezzi F, Mantica M, Startari U, Sciarra L. Clin Cardiol. 2022 Nov 29.